263 related articles for article (PubMed ID: 1339083)
1. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
Wild CP; Hudson GJ; Sabbioni G; Chapot B; Hall AJ; Wogan GN; Whittle H; Montesano R; Groopman JD
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):229-34. PubMed ID: 1339083
[TBL] [Abstract][Full Text] [Related]
2. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
3. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
4. HBsAg, aflatoxins and primary hepatocellular carcinoma.
Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
[TBL] [Abstract][Full Text] [Related]
5. [Immunological detection of aflatoxin-albumin adducts in children with chronic hepatitis B infection].
Alvarez MT; Castañeda C; Ruisanchez N; Aleaga M; García E; Escobar MP
G E N; 1995; 49(1):36-41. PubMed ID: 8566671
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.
Wild CP; Jiang YZ; Sabbioni G; Chapot B; Montesano R
Cancer Res; 1990 Jan; 50(2):245-51. PubMed ID: 2104776
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
[TBL] [Abstract][Full Text] [Related]
8. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
10. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children.
Wild CP; Fortuin M; Donato F; Whittle HC; Hall AJ; Wolf CR; Montesano R
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):555-61. PubMed ID: 8268773
[TBL] [Abstract][Full Text] [Related]
12. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
13. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin exposure and DNA damage in the comet assay in individuals from the Gambia, West Africa.
Anderson D; Yu TW; Hambly RJ; Mendy M; Wild CP
Teratog Carcinog Mutagen; 1999; 19(2):147-55. PubMed ID: 10332811
[TBL] [Abstract][Full Text] [Related]
15. Exposure biomarkers in chemoprevention studies of liver cancer.
Wild CP; Turner PC
IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
[TBL] [Abstract][Full Text] [Related]
16. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
Wild CP; Jansen LA; Cova L; Montesano R
Environ Health Perspect; 1993 Mar; 99():115-22. PubMed ID: 8391433
[TBL] [Abstract][Full Text] [Related]
17. Pilot survey of aflatoxin-albumin adducts in sera from Egypt.
Turner PC; Loffredo C; Kafrawy SE; Ezzat S; Eissa SA; Daly ME; Nada O; Abdel-Hamid M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 May; 25(5):583-7. PubMed ID: 18473213
[TBL] [Abstract][Full Text] [Related]
18. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
Autrup H; Seremet T; Wakhisi J; Wasunna A
Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
[TBL] [Abstract][Full Text] [Related]
20. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
